Premium
Concentration of Adiponectin in Peritoneal Fluid is Decreased in Women with Endometriosis
Author(s) -
Takemura Yuri,
Osuga Yutaka,
Harada Miyuki,
Hirata Tetsuya,
Koga Kaori,
Yoshino Osamu,
Hirota Yasushi,
Morimoto Chieko,
Yano Tetsu,
Taketani Yuji
Publication year - 2005
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/j.1600-0897.2005.00300.x
Subject(s) - endometriosis , peritoneal fluid , adiponectin , medicine , andrology , endocrinology , physiology , obesity , insulin resistance
Problem Adiponectin is a novel adipocytokine of extreme importance for the metabolism. Recent studies have indicated that adiponectin suppresses inflammation, angiogenesis, and fibrosis, which are central pathogenic factors for endometriosis. We addressed the possibility that adiponectin is implicated in endometriosis. Method of study We measured concentrations of adiponectin in peritoneal fluid (PF) of women with ( n = 54) or without ( n = 26) endometriosis using specific enzyme‐linked immunosorbent assay. Results Adiponectin concentrations in PF of women with endometriosis were significantly lower than those of women without endometriosis. With respect to the stages of the disease, the concentrations of adiponectin in women with stage III/IV endometriosis were significantly lower compared to those in women without endometriosis and with stage I/II endometriosis. Body mass index were comparable among the groups. Conclusions These findings imply that adiponectin may be an anti‐endometriotic factor, possibly due to its anti‐inflammatory, anti‐angiogenic, and anti‐fibrotic properties.